SCH 527123

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SCH 527123, covering 2015-03-26 to 2015-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1) [Phase 2]